Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 2.450E-08 | 5.335E-05 | CA1, CA12, CA2, CA4, CA6, CA7, CA9 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 7.235E-07 | 9.267E-04 | CA2, CA7 |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 3.614E-06 | 4.142E-03 | CA1, CA2 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 6.030E-25 | 1.313E-20 | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 1.656E-20 | 1.803E-16 | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 5.018E-18 | 2.185E-14 | CA1, CA12, CA2, CA4, CA6, CA7, CA9 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00910 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.724E-24 | 2.069E-23 | CA12; CA1; CA2; CA4; CA7; CA6; CA9; CA14 |
hsa04964 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 5.661E-05 | 3.397E-04 | CA2; CA4 |
hsa04966 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.342E-02 | 4.471E-02 | CA2 |
hsa00052 | Galactose metabolism_Homo sapiens_hsa00052 | 1.490E-02 | 4.471E-02 | GAA |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9 |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CA9 |
K00-K95: Diseases of the digestive system | Duodenal ulcers | K25-K27 | CA2; CA1 |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | MAPT |
E00-E89: Endocrine, nutritional and metabolic diseases | Pompe's disease | E74.02 | GAA |
C00-D49: Neoplasms | Renal cancer | C64 | CA9 |
G00-G99: Diseases of the nervous system G00-G99 | Central nervous system disease | G00-G99 | MAPT |
H00-H59: Diseases of the eye and adnexa | Chronic glaucoma | H40-H42 | CA1 |
H00-H59: Diseases of the eye and adnexa | Glaucoma | H40-H42 | CA1; CA1 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CA2 |
I00-I99: Diseases of the circulatory system | High blood pressure | I10-I16 | CA2 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cognitive disorders | F01-F07, F04, F05, R41.3 | MAPT |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9 |
C00-D49: Neoplasms | Breast cancer | C50 | CA9 |
C00-D49: Neoplasms | Cancer | C00-C96 | CA1; CA9 |
I00-I99: Diseases of the circulatory system | Edema associated with congestive heart failure | I50, R60.9 | CA2 |
G00-G99: Diseases of the nervous system G00-G99 | Neurodegenerative disease | G30-G32 | MAPT |
NA: NA | Edema | NA | CA2 |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA2; CA4 |
H00-H59: Diseases of the eye and adnexa | Ocular hypertension | H40.0 | CA4; CA4 |